Nivolumab-Ipilimumab Plus Cryoablation in Pediatric, Young Adult Patients With Relapsed/Refractory Solid Tumors

Researchers are evaluating cryoablation plus dual checkpoint inhibition in pediatric and young adult patients with relapsed or refractory solid tumors.

Related Keywords

Washington ,United States ,Marie Nelson ,Bristol Myers Squibb ,Children National Research Institute ,Neoadjuvant Dual Checkpoint Inhibition ,Cryoablation Therapy ,Young Adults With ,Refractory Solid ,National Research Institute ,